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Significant advances in oncology have been made in
recent decades. In general, the mortality rates associ-
ated with most cancers are now decreasing, and a
significant number of new treatments are now avail-
able for cancer patients. As oncologists use more
complex treatments to cure patients or to prolong their
survival, recognition and management of treatment-
related toxicity takes on critical importance.
In this issue of Current Oncology, subtitled
“Going Beyond Efficacy,” leaders from across the
country focus on some serious issues that are being
faced by cancer patients. We are delighted to have
involvement from many different specialties, high-
lighting the multidisciplinary nature of cancer
management.
• A common short-term toxicity of cancer treat-
ment is nausea and vomiting. Dr. David Warr ad-
dresses this issue and discusses recent advances
in the management of this troublesome symptom.
• As the complexity of treatments increases, and
as combination chemotherapy becomes more
common, treatment-related anemia and neutro-
penia need to be addressed. Dr. Barb Melosky
presents up-to-date information on anemia in can-
cer patients and specifically addresses recent
guidelines for, and safety concerns with, eryth-
ropoiesis-stimulating agents. (An upcoming ar-
ticle in the journal will also address neutropenia.)
• As therapies become more complex and as cure
rates improve in early-stage settings, the long-
term sequelae of adjuvant treatment of cancer
must be considered. A common concern in the
patient population with breast cancer is the risk
of cardiac toxicity associated with cancer treat-
ment. Dr. Kathryn Towns, Dr. Philippe Bedard,
and I present data on the risk of cardiac toxicity
associated with adjuvant therapy in breast cancer.
• Another significant concern related to cancer
treatment is the development of bone loss.
Dr. Aliya Khan provides an endocrinologist’s per-
spective of bone loss in relation to cancer treat-
ment—its implication and its management.
• In the metastatic setting, one of the main goals of
treatment is to provide optimal palliation. Dr. Jeff
Myers, a palliative care physician, discusses the
basics of cancer pain management and also pre-
sents information on new medical and interven-
tional therapies.
• In advanced disease, bone metastases commonly
occur. Dr. Bianca Petrut and colleagues provide
a primer on the management of bone metastases
in breast cancer.
• Thrombosis presents a serious risk of complica-
tion in cancer patients. Dr. Agnes Lee discusses
the most recent evidence on the prevention and
treatment of venous thromboembolism in cancer
patients.
These authors and I all hope that readers will find
this supplementary issue of Current Oncology to be
clinically meaningful as they focus on “going beyond
efficacy” to address some of the serious issues faced
by cancer patients.
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